PK ! ?MV: : xl/worksheets/sheet1.xml
0
12
3434
55350754646621028180963195
6322577319666624120633244
7875982215
9212498144237404060327736
108615780944176883158920
11528644557210104681951
127108710960
131365355049474820
144283178770854362
158130085800
1683333632381
17671191075111302668542
18
19-34083-36669-67968-76568
20-22443466-156-1715
2181238123
22403257148261204
23-32295-32509-63298-76956
2434824-2175849728-8414
25264821863007-105987
2632176-239444672197573
27-1764411948-254835498
2814532-1199621238103071
29
300.1-0.080.140.7
310.1-0.080.140.6899999999999999
32
30148996147392148507147286
31151986147392151606148309
PK ! V V xl/worksheets/sheet2.xml
33
12
3434
2632176-239444672197573
27-1764411948-254835498
2814532-1199621238103071
34
35182-2967-6184-8102
36704-977421476-72432
37-4486471-775040927
38438-62707542-39607
3914970-182662878063464
PK ! pj6 6 xl/worksheets/sheet3.xml
40
4142
43
44
45278306341378
4648475743
47652015638895
48523385490649
4910379873467
5011241407
5115634751551539
52468415477754
53549091522814
5412933251304626
554106533947
562168924792
57667779541
58858676
591921622344
6040230534006033
61
62
63596227611867
643046144228
6582376474
6622013978
6728061794
6881000
69329307561
70672862676902
7127201172735264
723722436440
733472330182
742013123049
75616432318
76860193
7787141584
786325583365
7929458072972395
80
811411211804
82
8388
8414901475
8515221522
86642657628413
87-265583-286821
88-33979-41318
89346107303271
904416541661
91390272344932
9240230534006033
PK ! r&6 6 xl/worksheets/sheet4.xml
93
2
34
94
954672197573
96
97112037116155
981241251
9944734214
218-123
1007103175
1011296210202
1022580534708
10327644156
104
47-1316775769
48-54580-33182
1058-110069
106-239888772
507383633
107-2113715172
108-3912-139
10996195228267
110
111-19585-15919
112-16678
113-500-1050
114-73828-254000
115-95580-270969
116
1178180000
118-33876-17072
1198-4102
120681158
121-2378-557
122-275518
123-93-530
124-10008
125-64217157897
126-366255
127-63968115450
128347121152822
129283153268272
130278306266143
13148472129
129283153268272
132
1336144168433
13446104518
135
13613736033
1381371573
13930099137
1406100137
PK ! !u0 0 xl/worksheets/sheet5.xml
141
142143144145146147148149
150151150151
15214871514851521171522634484-280115-343614369336670813079
958888814532815461299932183
15388888890921828
1018888763288876328
1545888988-458
1554895885328-56-789-3088
1568888883483567048
1578888888-16644-16644-1150
1588888888200020008
15914920914901521171522642657-265583-339794416539027214112
PK ! {_0 0 xl/worksheets/sheet6.xml
142143144145146147148149
150151150151
16014767414751521171522628413-286821-413184166134493211804
958888821238821504427423979
153888888-3049-3135-61848
101888812962888129628
1542492886868-34276818
155128613885968-169-2897-24578
368888881059110885214768
1618888888-25880-25880-1671
1588888888200020008
15914920914901521171522642657-265583-339794416539027214112
PK ! IƞC. C. xl/worksheets/sheet7.xml
141
142143144145146147148149
150151150151
16214731114721521171522611600-262813-334058508240345812563
16388888-119968-12168-24164220
164888888-1460-1507-29678
1018888566388856638
154561881538-651538
165126188888-15-257-1838
166888888-4810-4964-97748
1578888888-1170-1170-403
16714749314741521171522617504-274809-396966502137101612380
PK ! WL2/ / xl/worksheets/sheet8.xml
142143168169170171172149
150151150151
17314707014701521171522606966-377880-68114778346788137
26888881030718-6806962651308
174888888-3985-4117-81028
101888810202888102028
154581881588-651588
1553653881788-15-859-6938
36888888-35622-36810-724328
1578888888-1170-1170-403
17588888888811475
16714749314741521171522617504-274809-396966502137101612380
PK ! rCo o xl/worksheets/sheet9.xml
176
17774440
17830099
179500
1805600
181-7117
182103522
PK ! Gb xl/worksheets/sheet10.xml
183
184
185112
46500
49381
1865375
5326530
18773800
559367
188116065
631239
1899177
190127
19110543
902000
192103522
PK ! 4q q xl/worksheets/sheet11.xml
193
185254000
19435033
1956855
1961000
197-2640
182294248
PK ! ]yb
b
xl/worksheets/sheet12.xml
198
199
4746702
4871908
4911316
5061
1865278
53103679
54130800
565544
188375288
6362489
1081532
745544
19169565
8111475
192294248
PK ! mCP P xl/worksheets/sheet13.xml
200201
20266700203
20422000205
20628600207
20813000209
210500211
130800
PK ! <ٚ xl/worksheets/sheet14.xml
212
12
3434
55350754647551028372994156
2634172-262254919985935
2815523-141042247596390
PK ! Ѧ
xl/worksheets/sheet15.xml
213
12
3434
214215216216217
218219220221221
222223221221224
PK ! )r/8 /8 xl/worksheets/sheet16.xml
225
12
3434
226
227967797221559022776
22811165489277218357177919
229-261955-820216779
23010662896228202919195810
23136134251057144554359
23219703166253916137878
23333450165675248031422
234688167691343823408
2351046372401864117328
23614818104422769627584
23711143266682087451935
2381479615461947
239360437306559672945659145
240
24116012138723280828099
2306513074056132841142367
237749363281891711767
2428863594256184566182233
243
24448316318399381563425
24529172250736024446451
24657804511109597924
2472735242456514017
2488600363847170669121817
2495350754646621028180963195
PK ! , xl/worksheets/sheet17.xml
250251252253
25462880422690174984131088
2551528660524315829257108
256-1650651-52658-48441-89856
1595068132246318483598340
PK ! T< < xl/worksheets/sheet18.xml
257
258259
3434
260
2814532-1199621238103071
261
262148996147392148507147286
263
2648378815278
265215382284745
266151986147392151606148309
267
300.1-0.080.140.7
310.1-0.080.140.6899999999999999
PK ! " " xl/worksheets/sheet19.xml
258259
3434
264347-14008-4347-1671-1
26589372-488
2685169-23054-45169-23054-2
269152117-3152117-4152117-3152117-3
PK ! :
xl/worksheets/sheet20.xml
270
271272
27311828371291785
274-1546-1396
275-506813-628804
276-22463-22690
277-530822-652890
47652015638895
PK ! B B xl/worksheets/sheet21.xml
278
271272
214279279
218223280
222281219
PK ! +R xl/worksheets/sheet22.xml
282
271272
283216835209180
2844699140937
285259559240532
286523385490649
PK ! \ fD D xl/worksheets/sheet23.xml
287
288
41289290291292
293
2943242713732427137
2951484813714848137
29661001371376100
42
293
2945390313753903137
2951400713714007137
PK ! A A xl/worksheets/sheet24.xml
297
298299300301302
303500304305306307308
309310306311312
313314306315314
3165600304317306317317
309310306311318
3133143062032319
PK ! | xl/worksheets/sheet25.xml
320
4142
321322323322323
32478324277853903
PK ! e. xl/worksheets/sheet26.xml
325
271272
326522814419504
32726530103679
328-253-369
329549091522814
PK ! ' xl/worksheets/sheet27.xml
297
4142
330331332333331332333
334
3358.51179545-3974597820861153096-328587824509
3365.3133800-4554688254133800-33078100722
2771313345-4430058703401286896-361665925231
33742298584229853793958379395
3381736330-44300512933251666291-3616651304626
PK ! xl/worksheets/sheet28.xml
339
12
3434
34043520439768519286552
PK ! @ xl/worksheets/sheet29.xml
341
34287054
343162708
314149824
344139771
345100382
34656016
347174585
289870340
PK ! xl/worksheets/sheet30.xml
348
349350240351352353
53604378863586003137535075
620415448683697408322577
915628339952162638212498
101179720656135994010586157
114343194338852864
12710888710
13134025881365
1481649137764283
3549900598222173-4388167119
PK ! n7"L L xl/worksheets/sheet31.xml
355350240351356357
56729451845661706691371028180
6389452968811377878624120
928349387685328828404060
1030559405372730378484176883
11795482149888101046
12710888710
13492225884947
14816142256477085
168088283363
354167674256094157-84414113026
PK ! ٥?/ / xl/worksheets/sheet32.xml
358350240359356357
53065599425663847137464662
621890950229505288319666
7759888759
98689144027133198144237
101280216870156473562580944
114031652568845572
1335508883550
1432482813811787
3603050-1750881300
16333888333
3542651623569-2328-3700610751
PK ! w:nv v xl/worksheets/sheet33.xml
361350240359356357
5659145182233121817137963195
643777498047974238633244
722158882215
921915684186243948327736
1029425378122643565248158920
1169350126018881951
12960888960
1348155884820
1432482839564362
155550250885800
163798820022381
35410835333436-2041-7120668542
PK ! E
xl/worksheets/sheet34.xml
362
363
364365
3663673434
368369137137137137
3703711371371137
PK ! 㨭 xl/worksheets/sheet35.xml
372
363
364365
3663673434
37337413721372
37537613713732
377378137137137137
PK ! xl/worksheets/sheet36.xml
379
380381382
383-78327764-68
384-6643-34560-41203
385-22-25-47
386-14497-26821-41318
384-3049105917542
385-81-122-203
387-17627-16352-33979
PK ! S
xl/worksheets/sheet37.xml
388
271272
38913031696
39071026916
39111893565
3921116911882
39353785542
3944387517117
395100834913
3962369921836
39710379873467
PK ! P $ $ xl/worksheets/sheet38.xml
398
258259
3434
55350754646621028180963195
6322577319666624120633244
7875982215
9212498144237404060327736
108615780944176883158920
11528644557210104681951
127108710960
131365355049474820
144283178770854362
158130085800
1683333632381
17671191075111302668542
23-32295-32509-63298-76956
2434824-2175849728-8414
25264821863007-105987
2632176-239444672197573
PK ! [k xl/worksheets/sheet39.xml
226
258259
3434
5360437306559672945659145
6204154218909389452437774
7875982215
915628386891283493219156
1011797128023055929425
1143431403167954869350
127108710960
131340355049224815
1483248324
158305085550
16833380379
179900526516167674108353
PK ! g
xl/worksheets/sheet40.xml
240
258259
3434
58863594256184566182233
648683502299688198047
939952440278768584186
1020656168704053737812
11943352562149812601
13258255
1416821682
158-17508250
179822235692560933436
PK ! hpڇ xl/worksheets/sheet41.xml
348
258259
3434
58600363847170669121817
6697405052813778797423
916263133193288224394
1013599156472730326435
14491814228
3542173-23284157-2041
PK ! tlr
r
xl/worksheets/sheet42.xml
399
259
34
400
40196195228267
402-95580-270969
403-64217157897
404-366255
127-63968115450
PK ! n
xl/worksheets/sheet43.xml
405
406407
10.1408
31.1409
31.2409
31.3410
32.1411
32.2411
32.3412
101413
104414
PK ! 齨 xl/worksheets/sheet44.xml
415
416417418
419
420
PK ! Ⱦ xl/worksheets/sheet45.xml
415
416417421
422
423
PK ! oV xl/worksheets/sheet46.xml
415
416417424
425
426
PK ! U xl/worksheets/sheet47.xml
427
416417418
419
428
429
PK ! o xl/worksheets/sheet48.xml
427
416417421
422
430
429
PK ! B xl/worksheets/sheet49.xml
427
416417424
425
431
432
PK ! H p
xl/workbook.xml
PK ! VS S xl/sharedStrings.xml
Consolidated Statements of OperationsThree Months Ended June 30,Six Months Ended June 30,20212020Net revenueCost of goods soldCost of goods sold impairment charges—Gross profitSelling, general and administrativeResearch and developmentIn-process research and development impairment chargesIntellectual property legal development expensesAcquisition, transaction-related and integration expensesCharges related to legal matters, netRestructuring and other chargesOperating incomeOther (expense) income:Interest expense, netForeign exchange (loss) gain, netGain on sale of international businesses, netOther income, netTotal other expense, netIncome (loss) before income taxesProvision for (benefit from) income taxesNet income (loss)Less: Net (income) loss attributable to non-controlling interestsNet income (loss) attributable to Amneal Pharmaceuticals, Inc.Net income (loss) per share attributable to Amneal Pharmaceuticals, Inc.'s class A common stockholders:BasicDilutedWeighted-average common shares outstanding:Consolidated Statements of Comprehensive Income (Loss)Other comprehensive income (loss):Foreign currency translation adjustments arising during the periodUnrealized loss on cash flow hedge, net of taxLess: Other comprehensive (income) loss attributable to non-controlling interestsOther comprehensive income (loss) attributable to Amneal Pharmaceuticals, Inc.Comprehensive income (loss) attributable to Amneal Pharmaceuticals, Inc.Consolidated Balance SheetsJune 30, 2021December 31, 2020AssetsCurrent assets:Cash and cash equivalentsRestricted cashTrade accounts receivable, netInventoriesPrepaid expenses and other current assetsRelated party receivablesTotal current assetsProperty, plant and equipment, netGoodwillIntangible assets, netOperating lease right-of-use assetsOperating lease right-of-use assets - related partyFinancing lease right-of-use assetsFinancing lease right-of-use assets - related partyOther assetsTotal assetsLiabilities and Stockholders' EquityCurrent liabilities:Accounts payable and accrued expensesCurrent portion of long-term debt, netCurrent portion of operating lease liabilitiesCurrent portion of operating and financing lease liabilities - related partyCurrent portion of financing lease liabilitiesCurrent portion of note payable - related partyRelated party payable - short termTotal current liabilitiesLong-term debt, netNote payable - related partyOperating lease liabilitiesOperating lease liabilities - related partyFinancing lease liabilitiesFinancing lease liabilities - related partyRelated party payable - long termOther long-term liabilitiesTotal long-term liabilitiesCommitments and contingencies (Notes 5 and 13)Redeemable non-controlling interestsStockholders' EquityPreferred stock, $0.01 par value, 2,000 shares authorized; none issued at both June 30, 2021 and December 31, 2020Class A common stock, $0.01 par value, 900,000 shares authorized at both June 30, 2021 and December 31, 2020; 149,209 and 147,674 shares issued at June 30, 2021 and December 31, 2020, respectivelyClass B common stock, $0.01 par value, 300,000 shares authorized at both June 30, 2021 and December 31, 2020; 152,117 shares issued at both June 30, 2021 and December 31, 2020Additional paid-in capitalStockholders' accumulated deficitAccumulated other comprehensive lossTotal Amneal Pharmaceuticals, Inc. stockholders' equityNon-controlling interestsTotal stockholders' equityTotal liabilities and stockholders' equityConsolidated Statements of Cash FlowsCash flows from operating activities:Net incomeAdjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortizationUnrealized foreign currency lossAmortization of debt issuance costs and discountIntangible asset impairment chargesStock-based compensationInventory provisionOther operating charges and credits, netChanges in assets and liabilities:Income taxes receivable associated with the CARES ActPrepaid expenses, other current assets and other assetsAccounts payable, accrued expenses and other liabilitiesRelated party payablesNet cash provided by operating activitiesCash flows from investing activities:Purchases of property, plant and equipmentDeposits for future acquisition of property, plant, and equipmentAcquisition of intangible assetsAcquisitions, net of cash acquiredNet cash used in investing activitiesCash flows from financing activities:Proceeds from issuance of debtPayments of principal on debt, financing leases and otherPayments of deferred financing costsProceeds from exercise of stock optionsEmployee payroll tax withholding on restricted stock unit vestingTax distributions to non-controlling interestsPayments of principal on financing lease - related partyRepayment of related party noteNet cash (used in) provided by financing activitiesEffect of foreign exchange rate on cashNet (decrease) increase in cash, cash equivalents, and restricted cashCash, cash equivalents, and restricted cash - beginning of periodCash, cash equivalents, and restricted cash - end of periodCash and cash equivalents - end of periodRestricted cash - end of periodSupplemental disclosure of cash flow information:Cash paid for interestCash paid for income taxes, netSupplemental disclosure of non-cash investing and financing activity:Notes payable for acquisitions - related party$—Tax distribution to non-controlling interestsDeferred consideration for acquisition - related partyContingent consideration for acquisition - related partyConsolidated Statements of Changes in Stockholders' EquityClass A Common
StockClass B Common
StockAdditional
Paid-in CapitalStockholders'
Accumulated DeficitAccumulated
Other
Comprehensive LossNon-
Controlling InterestsTotal EquityRedeemable Non-Controlling InterestsSharesAmountBalance at April 1, 2021Foreign currency translation adjustmentExercise of stock optionsRestricted stock unit vesting, net of shares withheld to cover payroll taxesUnrealized gain on cash flow hedge, net of taxTax distributionsNon-controlling interests from the KSP AcquisitionBalance at June 30, 2021Balance at January 1, 2021Tax DistributionsBalance at April 1, 2020Net (loss) incomeForeign currency translation
adjustmentRestricted stock unit vesting,
net of shares withheld to
cover payroll taxesUnrealized loss on cash flow
hedge, net of taxBalance at June 30, 2020Additional
Paid-in
CapitalStockholders'
Accumulated
DeficitAccumulated
Other
Comprehensive
LossNon-
Controlling
InterestsTotal
EquityBalance at January 1, 2020Foreign currency translation adjustmentRedeemable non-controlling interests from the Rondo AcquisitionsNote 15. Related Party TransactionsCash, including working capital paymentsDeferred consideration (1)Contingent consideration (regulatory milestones) (2)Contingent consideration (royalties) (2)Settlement of Amneal trade accounts payable due to KSP (3)Fair value consideration transferredNote 10. Fair Value MeasurementsPreliminary Fair Values as of
April 2, 2021CashProperty, plant and equipmentIntangible assetsTotal assets acquiredOperating lease liabilityRelated party payableTotal liabilities assumedFair value of consideration transferredAvKARE and R&S AcquisitionsSellers Notes (1)Settlement of Amneal trade accounts receivable from R&S (2)Short-Term Seller Note (3)Working capital adjustment (4)Business Combinations,Final Fair Values as of
January 31, 2020Fair ValuesWeighted-Average
Useful LifeGovernment licenses7 yearsGovernment contracts4 yearsNational contracts5 yearsCustomer relationships10 yearsTrade name6 yearsUnaudited Pro Forma InformationConcentration of RevenueCustomer A35%32%34%Customer B26%27%25%Customer C22%24%Disaggregated RevenueGenericsAnti-InfectiveHormonalAntiviral (1)Central Nervous SystemCardiovascular SystemGastroenterologyOncologyMetabolic Disease/EndocrineRespiratoryDermatologyOther therapeutic classesInternational and otherTotal Generics net revenueSpecialtyHormonal/MetabolicTotal Specialty net revenueAvKARE (2)DistributionGovernment LabelInstitutionalOtherTotal AvKARE net revenueTotal net revenueContract
Charge - Backs
and Sales
Volume
AllowancesCash Discount
AllowancesAccrued
Returns
AllowanceAccrued
Medicaid and
Commercial
RebatesBalance at December 31, 2020Provision related to sales recorded in the periodCredits/payments issued during the period6. Earnings (Loss) per ShareThree Months Ended
June 30,Six Months Ended
June 30,Numerator:Denominator:Weighted-average shares outstanding - basicEffect of dilutive securities:Stock optionsRestricted stock unitsWeighted-average shares outstanding - dilutedNet earnings (loss) per share attributable to Amneal Pharmaceuticals, Inc.'s class A common stockholders:Performance stock unitsShares of class B common stock8. Trade Accounts Receivable, NetJune 30,
2021December 31,
2020Gross accounts receivableAllowance for credit lossesContract charge-backs and sales volume allowancesCash discount allowancesSubtotalConcentration of Receivables39%20%23%9. InventoriesRaw materialsWork in processFinished goodsTotal inventoriesAssets and Liabilities Measured at Fair Value on a Recurring BasisFair Value Measurement Based onTotalQuoted
Prices in
Active
Markets
(Level 1)Significant
Other
Observable
Inputs
(Level 2)Significant
Unobservable
Inputs
(Level 3)LiabilitiesInterest rate swap (1)Deferred compensation plan liabilities (2)Contingent consideration liability (3)Note 3. AcquisitionsContingent Consideration LiabilityFair Value as of June 30, 2021 (in thousands)Unobservable inputRangeWeighted Average (1)Regulatory MilestonesDiscount rate2.4%-4.4%2.7%Probability of payment1.8%20.0%16.7%Projected year of payment20232027Royalties11.0%17.4%2029Interest Rate Derivative Cash Flow HedgeDerivatives Designated as Hedging InstrumentsBalance Sheet
ClassificationFair ValueVariable-to-fixed interest rate swap12. Goodwill and Intangible AssetsBalance, beginning of periodGoodwill acquired during the periodCurrency translationBalance, end of periodWeighted-Average
Amortization Period
(in years)CostAccumulated
AmortizationNetAmortizing intangible assets:Product rightsOther intangible assetsIn-process research and developmentTotal intangible assetsAcquisitionsAmortizationFuture
AmortizationRemainder of 20212022202420252026ThereafterAvKAREThree Months Ended June 30, 2021Generics (1)AvKARE (1)Corporate and OtherTotal CompanyOperating income (loss)Six Months Ended June 30, 2021Corporate
and OtherTotal
CompanyThree Months Ended June 30, 2020AvKARE (1,2)Charges (gains) related to legal matters, netSix Months Ended June 30, 2020Agreements with Kashiv Not Affected by the Acquisition of KSPAmounts in millionsResearch and development expenses for the three months ended June 30,Research and development expenses for the six months ended June 30,ProductsAgreement DateFilgrastim and PEG-Filgrastim (1)October 2017Ganirelix Acetate and Cetrorelix Acetate (2)August 2020Agreements with Kashiv Included in the Acquisition of KSPLevothyroxine Sodium (1)June 2019K127 (2)November 2019Posaconazole (3)May 2020Changes in Accumulated Other Comprehensive Loss by Component (in thousands):Foreign
currency
translation
adjustmentUnrealized
gain (loss) on cash
flow hedge, net
of taxAccumulated
other
comprehensive
lossBalance December 31, 2019Other comprehensive loss before reclassificationReallocation of ownership interestsBalance December 31, 2020Balance June 30, 202117. Prepaid Expenses and Other Current AssetsDeposits and advancesPrepaid insurancePrepaid regulatory feesIncome and other tax receivablesPrepaid taxesOther current receivables (1)Chargebacks receivable (2)Other prepaid assetsTotal prepaid expenses and other current assetsConsolidated ResultsCash FlowsCash provided by (used in):Operating activitiesInvesting activitiesFinancing activitiesEffect of exchange rate changes on cashItem 6. ExhibitsExhibit No.Description of DocumentAmneal Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended and restated on May 5, 2021 . †*Certification of the Co - Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*Certification of the Co - Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 formatted in inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Statements of Operations for each of the three and six months ended June 30, 2021 and 2020, (ii) Consolidated Statements of Comprehensive Income (Loss) for each of the three and six months ended June 30, 2021 and 2020, (iii) Consolidated Balance Sheets as of June 30, 2021 and December 31, 2020, (iv) Consolidated Statements of Cash Flows for the six months ended June 30, 2021 and 2020, (v) Consolidated Statements of Changes in Stockholders' Equity for each of the three and six months ended June 30, 2021 and 2020 and (vi) Notes to Consolidated Financial Statements.*Cover Page Interactive Data File – The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 is formatted in Inline XBRL (included as Exhibit 101).SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002August 9, 2021By:/s/ Chirag PatelChirag PatelPresident and Co-Chief Executive Officer
(Co-Principal Executive Officer)/s/ Chintu PatelChintu PatelCo-Chief Executive Officer
(Co-Principal Executive Officer)/s/ Anastasios KonidarisAnastasios KonidarisExecutive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002President and Co-Chief Executive Officer(Co-Principal Executive Officer)Co-Chief Executive OfficerExecutive Vice President and Chief Financial Officer(Principal Financial and Accounting Officer)PK ! 0? docProps/app.xml
Microsoft Excel0falseWorksheets49operationscomprehensive income lossconsolidated balance sheetscash flowschanges in stockholders eqchanges in stockholders eq-1changes in stockholders eq-2changes in stockholders eq-3note 15 related party trannote 10 fair value measureavkare and rs acquisitionsbusiness combinationsbusiness combinations-1unaudited pro forma informconcentration of revenuedisaggregated revenuedisaggregated revenue-16 earnings loss per share6 earnings loss per share-18 trade accounts receivablconcentration of receivables9 inventoriesassets and liabilities meanote 3 acquisitionsinterest rate derivative c12 goodwill and intangiblenote 3 acquisitions-1acquisitionsacquisitions-1avkareavkare-1avkare-2avkare-3agreements with kashiv notagreements with kashiv incchanges in accumulated oth17 prepaid expenses and otconsolidated resultsgenericsspecialtyavkare-4cash flows-1item 6 exhibitssection 302 of the sarbanesection 302 of the sarbane-1section 302 of the sarbane-2section 906 of the sarbanesection 906 of the sarbane-1section 906 of the sarbane-2falsefalsefalse12.0000PK ! %P P docProps/core.xml
2021-08-09T20:47:52Z2021-08-09T20:47:52ZPK ! mY7 7 [Content_Types].xml
PK ! Js
xl/styles.xml
PK ! FTR R xl/theme/theme1.xml
PK ! IK K _rels/.rels
PK ! || | xl/_rels/workbook.xml.rels
PK ! ?MV: : xl/worksheets/sheet1.xmlPK ! V V : xl/worksheets/sheet2.xmlPK ! pj6 6 UQ xl/worksheets/sheet3.xmlPK ! r&6 6 xl/worksheets/sheet4.xmlPK ! !u0 0 0 xl/worksheets/sheet5.xmlPK ! {_0 0 \ xl/worksheets/sheet6.xmlPK ! IƞC. C. xl/worksheets/sheet7.xmlPK ! WL2/ / #O xl/worksheets/sheet8.xmlPK ! rCo o ? xl/worksheets/sheet9.xmlPK ! Gb xl/worksheets/sheet10.xmlPK ! 4q q xl/worksheets/sheet11.xmlPK ! ]yb
b
K xl/worksheets/sheet12.xmlPK ! mCP P xl/worksheets/sheet13.xmlPK ! <ٚ k xl/worksheets/sheet14.xmlPK ! Ѧ
< xl/worksheets/sheet15.xmlPK ! )r/8 /8 & xl/worksheets/sheet16.xmlPK ! , xl/worksheets/sheet17.xmlPK ! T< < xl/worksheets/sheet18.xmlPK ! " " :! xl/worksheets/sheet19.xmlPK ! :
2 xl/worksheets/sheet20.xmlPK ! B B < xl/worksheets/sheet21.xmlPK ! +R GC xl/worksheets/sheet22.xmlPK ! \ fD D ^K xl/worksheets/sheet23.xmlPK ! A A _ xl/worksheets/sheet24.xmlPK ! | Qp xl/worksheets/sheet25.xmlPK ! e. -y xl/worksheets/sheet26.xmlPK ! ' ` xl/worksheets/sheet27.xmlPK ! xl/worksheets/sheet28.xmlPK ! @ ֣ xl/worksheets/sheet29.xmlPK ! xl/worksheets/sheet30.xmlPK ! n7"L L xl/worksheets/sheet31.xmlPK ! ٥?/ / D xl/worksheets/sheet32.xmlPK ! w:nv v xl/worksheets/sheet33.xmlPK ! E
W xl/worksheets/sheet34.xmlPK ! 㨭 , xl/worksheets/sheet35.xmlPK ! ; xl/worksheets/sheet36.xmlPK ! S
>J xl/worksheets/sheet37.xmlPK ! P $ $ W xl/worksheets/sheet38.xmlPK ! [k { xl/worksheets/sheet39.xmlPK ! g
xl/worksheets/sheet40.xmlPK ! hpڇ < xl/worksheets/sheet41.xmlPK ! tlr
r
xl/worksheets/sheet42.xmlPK ! n
xl/worksheets/sheet43.xmlPK ! 齨 i xl/worksheets/sheet44.xmlPK ! Ⱦ < xl/worksheets/sheet45.xmlPK ! oV xl/worksheets/sheet46.xmlPK ! U xl/worksheets/sheet47.xmlPK ! o xl/worksheets/sheet48.xmlPK ! B xl/worksheets/sheet49.xmlPK ! H p
! xl/workbook.xmlPK ! VS S E xl/sharedStrings.xmlPK ! 0? X docProps/app.xmlPK ! %P P /d docProps/core.xmlPK ! mY7 7 f [Content_Types].xmlPK ! Js
xl/styles.xmlPK ! FTR R @ xl/theme/theme1.xmlPK ! IK K ì _rels/.relsPK ! || | 7 xl/_rels/workbook.xml.relsPK : :